Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 known ✓ | Q13464 | 20/20 | 0.98 |
| ▸ | ROCK2 known ✓ | O75116 | 18/20 | 0.98 |
| ▸ | SGK1 | O00141 | 1/20 | 0.88 |
| ▸ | AKT1 | P31749 | 1/20 | 0.88 |
| ▸ | GSK3B | P49841 | 1/20 | 0.88 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.88 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.88 |
| ▸ | DMPK | Q09013 | 1/20 | 0.88 |
| ▸ | MYLK | Q15746 | 1/20 | 0.88 |
| ▸ | CDC42BPA | Q5VT25 | 1/20 | 0.88 |
| ▸ | PRKACA | P17612 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29633094 | 1.00 | ROCK1 (0.98) | ROCK1ROCK2SGK1AKT1GSK3B | |
| SCHEMBL29431307 | 0.99 | ROCK1 (1.00) | ROCK1ROCK2SGK1AKT1GSK3B | |
| SCHEMBL2560201 | 0.99 | ROCK1 (1.00) | ROCK1ROCK2SGK1AKT1GSK3B | |
| SCHEMBL2551860 | 0.94 | ROCK1 (1.00) | ROCK1ROCK2SGK1AKT1GSK3B | |
| SCHEMBL23352214 | 0.91 | ROCK1 (0.85) | ROCK1ROCK2SGK1AKT1GSK3B | |
| SCHEMBL2554347 | 0.87 | ROCK1 (1.00) | ROCK1ROCK2SGK1AKT1GSK3B | |
| SCHEMBL2555028 | 0.87 | ROCK1 (1.00) | ROCK1ROCK2SGK1AKT1GSK3B | |
| SCHEMBL2560469 | 0.87 | ROCK2 (1.00) | ROCK1ROCK2SGK1AKT1GSK3B | |
| SCHEMBL2559909 | 0.87 | ROCK1 (1.00) | ROCK1ROCK2SGK1AKT1GSK3B | |
| SCHEMBL2557781 | 0.86 | ROCK1 (1.00) | ROCK1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200140827-A1 | A SUBSTRATE AND METHOD FOR THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2020-05-07 | — | — | US | claimed |
| EP-3630953-A1 | A SUBSTRATE AND METHOD FOR THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS | The Queen's University Of Belfast (GB) | 2020-04-08 | — | — | EP | claimed |
| WO-2018220081-A1 | A SUBSTRATE AND METHOD FOR THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2018-12-06 | — | — | WO | claimed |
| US-12618830-B2 | Methods, culture medias and devices for generating embryos in vitro from stem cells | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260062678-A1 | CELL REPLACEMENT THERAPY FOR PULMONARY DISEASES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2026-03-05 | — | — | US | disclosed |
| EP-3680325-B1 | PLATELET PRODUCTION METHOD, PLATELET PREPARATION PRODUCTION METHOD, AND BLOOD PREPARATION PRODUCTION METHOD | MEGAKARYON CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12467917-B2 | Reconstructing human early embryogenesis in vitro with pluripotent stem cells | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2025-11-11 | — | — | US | disclosed |
| EP-4581131-A1 | DIFFERENTIAL ADHESION AND TENSION GUIDED FORMATION OF STEM CELL DERIVED EMBRYOS | California Institute of Technology (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-4581130-A1 | METHODS AND CULTURE MEDIA FOR GENERATING EMBRYOS IN VITRO FROM PLURIPOTENT STEM CELLS | California Institute of Technology (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-4573186-A1 | CELL COMPOSITIONS AND METHODS OF USING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20250114470-A1 | THERAPY FOR POLYCYSTIC KIDNEY DISEASE | UNIVERSITY OF MASSACHUSETTS | 2025-04-10 | — | — | US | disclosed |
| EP-3630953-A1 | A SUBSTRATE AND METHOD FOR THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS | The Queen's University Of Belfast (GB) | 2020-04-08 | — | — | EP | disclosed |
| WO-2019217429-A1 | LUNG AND AIRWAY PROGENITORS GENERATED FROM HUMAN PLURIPOTENT STEM CELLS AND RELATED TREATMENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-11-14 | — | — | WO | disclosed |
| US-20190338250-A1 | METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND METHODS OF USE THEREOF | HOWARD HUGHES MEDICAL INSTITUTE | 2019-11-07 | — | — | US | disclosed |
| US-10443042-B2 | Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-10-15 | — | — | US | disclosed |
| US-10253298-B2 | Methods for generating stem cell-derived beta cells and methods of use thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-04-09 | — | — | US | disclosed |
| WO-2019059234-A1 | PLATELET PRODUCTION METHOD, PLATELET PREPARATION PRODUCTION METHOD, AND BLOOD PREPARATION PRODUCTION METHOD | 株式会社メガカリオン | 2019-03-28 | — | — | WO | disclosed |
| WO-2018220081-A1 | A SUBSTRATE AND METHOD FOR THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2018-12-06 | — | — | WO | disclosed |
| US-20160177267-A1 | SERUM-FREE IN VITRO DIRECTED DIFFERENTIATION PROTOCOL FOR GENERATING STEM CELL-DERIVED BETA CELLS AND USES THEREOF | HOWARD HUGHES MEDICAL INSTITUTE | 2016-06-23 | — | — | US | disclosed |
| US-20160177269-A1 | METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND METHODS OF USE THEREOF | HOWARD HUGHES MEDICAL INSTITUTE | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10253298-B2 | Methods for generating stem cell-derived beta cells and methods of use thereof | IAPP, RNASE1, PNLIP | ROCK1 2444/4885ROCK2 2425/4885SGK1 2687/4885 |
| US-20260062678-A1 | CELL REPLACEMENT THERAPY FOR PULMONARY DISEASES | WNT3A, BMP4, GSK3B | ROCK1 12/4885ROCK2 14/4885SGK1 262/4885 |
| US-12618830-B2 | Methods, culture medias and devices for generating embryos in vitro from stem cells | POU2F1, POU5F1, POU2F2 | ROCK1 2793/4885ROCK2 2165/4885SGK1 1762/4885 |
| US-20160177269-A1 | METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND METHODS OF USE THEREOF | IAPP, RNASE1, PNLIP | ROCK1 2444/4885ROCK2 2425/4885SGK1 2687/4885 |
| US-20190338250-A1 | METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND METHODS OF USE THEREOF | IAPP, RNASE1, PNLIP | ROCK1 2444/4885ROCK2 2425/4885SGK1 2687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.